Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1992-09-25
1995-03-21
Kim, Kay K. A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
4241851, 514 2, 514 8, 514 21, 514825, A61K 3900, A61K 3702, A61K 3712
Patent
active
053993470
ABSTRACT:
The present invention is directed to a method and pharmaceutical formulations for the treatment of autoimmune arthritis and animal models therefore in mammals, including humans, by the oral, enteral or by-inhalation administration of whole collagen protein or biologically active peptide fragments of collagen.
REFERENCES:
patent: 4804745 (1989-02-01), Koepff et al.
Thompson et al (1985) Clin. Exp. Immunol 64: 581-586.
Zhang et al (1990 Apr. 26, 1990) FASEBJ. 4(7): Abst No. 3264.
Phadke et al (1984) Arthritis and Rheumatism 27(7): 797-806.
Wells, H., J. Infect. Dis. 9:147 (1911).
Ngan, J. et al., J. Immunol. 120:861 (1978).
Gautam, S. C. et al., J. Immunol. 135:2975 (1985).
Titus, R. et al., Int. Arch. Allergy Appl. Immunol. 65:323 (1981).
Higgins, P. J. et al., J. Immunol. 140:440 (1988).
Lider, O. et al., J. Immunol. 142:748 (1989).
Bitar, D. M. et al., Cell. Immunol. 112:364 (1988).
Nagler-Anderson, C. et al., Proc. Natl. Acad. Sci. USA 83:7443 (1986).
Thompson, H. S. G. et al., Clin. Exp. Immunol. 64:581 (1985).
Swierkosz, J. E. et al., J. Immunol. 119:1501 (1977).
Lando, Z. et al., Nature 287:551 (1980).
Lando, Z. et al., J. Immunol. 126:1526 (1981).
Sriram, S. et al., Cell. Immunol. 75:378 (1983).
Alvord, E. C. et al., Annals of Neurol. 6:461 (1979).
Alvord, E. C. et al., Annals of Neurol. 6:469 (1979).
Alvord, E. C. et al., Annals of Neurol. 6:474 (1979).
Traugott, U. et al., J. Neurol. Sci. 56:65 (1982).
Raine, C. S. et al., Lab. Invest. 48:275 (1983).
McKenna, R. et al., Cell. Immunol. 81:391 (1983).
Strejan, G. et al., Cell. Immunol. 84:171 (1984).
McKenna, R. et al., Cell. Immunol. 88:251 (1984).
Burns, J. et al., Neurology 36:92 (1986).
Belik, Y. et al., Vopr. Med. Khim. 24:372 (1978).
Mowat, A. M., Immunol. Today 8:93 (1987).
Trentham, D. E. et al., J. Clin. Invest. 66:1109 (1980).
Myers, L. K. et al., J. Exp. Med. 170:1999 (1989).
Myers, L. K. et al., J. Immunol. 143:3976 (1989).
Kardys, E. et al., J. Immunol. 127:862 (1981).
Holoshitz, J. et al., J. Immunol. 131:2810 (1983).
Mokhtarian, F. et al., Nature 309:356 (1984).
Braley-Mullen, H. et al., Cell. Immun. 39:289 (1978).
McDermott, J. R. et al., J. Neurol. Sci. 46:137 (1980).
Raziuddin, S. et al., J. Immunol. 128:2073 (1982).
Alvord, E. C. et al., Ann. N.Y. Acad. Sci. 122:333 (1965).
Higgins, P. J. et al., J. Neuroimmunol. 16:77 (1987).
Higgins, P. J. et al., Annals of Neurol. 20:161, Abstract P154 (1986).
Whitacre, C. C. et al., Abstr. 6th Int'l. Congr. Immunol., Toronto (Jul. 1986) (Distrib. to Registered Attendees Upon Request, May 1986).
Whitacre, C. C. et al., Titles of Workshop Presentations No. 615-09, 5th Int'l. Congr. of Immunol. Kyoto, Japan (1983).
Schoen, R. T. et al., J. Immunol. 128:717 (1982).
Eylar, E. H., Adv. Exp. Med. Biol. 98:259 (1978).
Gonsette, R. E. et al., J. Neurol. 216:27 (1977).
Campbell, B. et al., Arch. Neurol. 29:10 (1973).
Hafler David A.
Trentham David E.
Weiner Howard L.
AutoImmune Inc.
Kim Kay K. A.
LandOfFree
Method of treating rheumatoid arthritis with type II collagen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating rheumatoid arthritis with type II collagen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating rheumatoid arthritis with type II collagen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1147390